Floor seatedSPRINGFIELD – A measure co-sponsored by State Senator Terry Link (D-Indian Hills) aimed at reducing skyrocketing prescription insulin costs for diabetics passed the Illinois Senate with bipartisan support Tuesday.

“Drug companies know that diabetics and their families will pay virtually anything for the insulin they need, and they’re taking advantage of that,” Link said. “It’s time we take a stand for the people we represent and put them ahead of the profits of the pharmaceutical industry.”

Senate Bill 667 caps out of pocket insulin expenses at $100 for a 30-day supply and directs the Illinois Attorney General’s office to investigate reasons for rising insulin costs.

According to the American Diabetes Association, there are more than 30 million Americans with diabetes, 7.4 million of which require prescription insulin every day to survive. However, the increasing costs associated with the medication have led many patients to ration their supply or seek care outside of the country.

“For diabetics, this medication isn’t optional, it’s necessary to survive,” Link said. “In Illinois, we need to ensure that all people have access to the medication they need, and this legislation is a major step toward achieving that goal.”

The measure would make Illinois the second state in the country to cap out of pocket insulin costs. Colorado became the first earlier this year.

Senate Bill 667 passed the Senate by a vote of 48-07. It will now move to the Illinois House of Representatives for further consideration.

Category: Latest

COVID19 Resources

COVID19 Updates